Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 3 September 2019
Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Clinical Trial in Spinal Fusion
Press Release, 20 August 2019
Kuros Biosciences Reports Results for First Half 2019
Kuros Interim Results, 2019
English version
Press Release, 24 July 2019
Kuros announces Gerhard Ries is stepping down as Board member
Minutes of the EGM, 17 July 2019
English version
Press Release, 17 July 2019
Extraordinary General Meeting of Kuros Biosciences approves all resolutions